Headlines

Meiji Seika to push new vaccine with SII in India

Meiji Seika, SII tie up to bring Japanese Encephalitis vaccine to India; Medreich eyes expansion TOKYO: Meiji Seika Pharma-owned Medreich Pharma is eyeing inorganic growth and more generics supply from India, while the parent has tied up with Serum Institute of India (SII) to launch Japanese Encephalitis vaccine in the country.“SII will take the required…

Read Full News

Resona Bank deepens ties with Tata Cap

MUMBAI: Japan’s Resona Bank on Monday announced a tie-up with Tata Capital to provide its clients better access to financing solutions and opportunities in India using the non-bank lender’s local network. The announcement follows a $20 million investment by Resona Bank as a limited partner in Tata Capital Growth Fund III LP, which invests in…

Read Full News

Trump’s ‘Operation Economic Outcast’ against Iran: What sanctions threat could mean for India

Indian exports to Iran declined from $3.5 billion in FY2019 to $1.2 billion in FY2026. Launching an ‘economic onslaught’ on Iran, US Treasury Secretary Scott Bessent said that President Donald Trump is making phone calls to world leaders with specific requests to stop all interactions with Iran.The move comes amid the ongoing US-Iran conflict which…

Read Full News